The rapid adoption of technology in healthcare also touched the area of diabetes care management; digitizing the available methods to provide more comfort and simplicity to the affected people. The sudden wave of smartphones had a great impact on the digital diabetes care as it brings forth several smart apps that help the consumers to track their blood glucose levels, diet and physical activities, sleep pattern, and so on at their fingertips. More innovations are being carried out to provide more compact and efficient solutions to diabetic people, especially the geriatric population in remote areas of the world.

The Global Digital Diabetes Management Market is is expected to cross around USD 20 billion by the end of 2024, registering a CAGR value of 24% during 2019 to 2025; as per the research report published by Research Cosmos.The growing adoption of technology and increasing acceptance of smart applications by consumers along with the extensive spread of diabetes in all the demographics, people are expected to drive the demand for digital diabetic solutions. The major benefit of these solutions is that they can be availed within the comfort of home, without any hospital visits or medical professional support. The portability offered by these digital solutions allows the patients to carry them anywhere without any hassle.

One of the most noteworthy trends in digital diabetes management is the introduction of wearable devices. These devices can be worn on the body with much ease and are capable to provide round the clock assistance to the consumer, along with the maintenance of style quotient. The advantage of these wearable could be continuous monitoring of the blood glucose levels of the person, providing required amounts of insulin to body without any external assistance, sharing patient condition to respective healthcare provider or doctor, providing regular alerts about health status, offering suggestions to improve health and so on and so forth.

The increasing acceptance for digital diabetes management has pushed many manufacturers in healthcare to concentrate more on the development of innovative solutions to grab the major chunk of the world profits. Several acquisitions, mergers, collaborations and new product launches have become the important strategy of many leading players to improve their market holdings. One such popular event in the recent years is the partnership of digital diabetes platform provider GlucoMe with the leading German pharmaceutical company Merck KGaA to offer the digital diabetes platform services to various hospitals in Vietnam, which has one of the fastest growing diabetic cases in the Asia-Pacific.

The major challenge these digital solutions face is to reach the rural population in many developing regions of the world. The lack of awareness about the availability of these features due to the improper publicity and initiatives from the government can be a stronghold for this market. Additionally, the high costs of smart devices and unstructured regularization of the products, which can lead to the availability of counterfeit products that are harmful to the body could act as limiting factors for the rapid adoption of the digital diabetes solutions among the global population.

However, the future looks more promising for the digital care in diabetes with the augmenting innovations in the technology such as data analytics and artificial intelligence (AI). These technologies will further intensify the services offered currently at more affordable prices. In particular, AI will play a prominent role in the increasing efficiency and care of these solutions. Similarly, the added style factor in wearable devices by several manufactures around the world will further create huge demand for digital diabetic solutions. Furthermore, the growing elderly population of the world, who prefer home healthcare will become the lucrative segment of end-users for these devices; pulling the market players to focus more on this section.

Globally, North America has been the demanding region with the significant market share in digital diabetes management market. The contribution from the developed nations of this region like the USA, Canada and Mexico has been tremendous in the recent years. The increasing cases of diabetes, rapid adoption of advanced technologies in medical care, sophisticated healthcare infrastructure, mounting number of geriatric populations, awareness about the benefits of these devices among the population and the favourable government reimbursements have been the driving factors for the growing demand of digital diabetes management in the North American nations.

Some of the prominent names in the global digital diabetes management market are Abbott Laboratories, Merck KGaA, Roche Diagnostics, AgaMatrix, Glooko Inc, Tandem Diabetes Care, Medtronic, Dexcom, Lifescan, DarioHealth, Tidepool, Insulet Corporation, B. Braun, Ascensia Diabetes Care, and others. All these players are investing in their R&D activities to implement and introduce more innovative solutions in the world digital diabetes management market.

About the author:

Kevin Stewart is currently working with Research Cosmos as Market Research Manager; a firm that does Global Market Intelligence.

The post Digital Diabetes Management Market appeared first on InnoHEALTH magazine.

Age and disease demographics are changing rapidly across the globe. The number of people above 65 years is expected to double and constitute nearly 17% of the world population by 2050. The chronic disease incidence rate is expected to rise to 57% by 2020. These figures highlight the need to enhance the quality and efficiency of care with quick response time to health-related emergencies.

Ideas that cut across medicine, biological and engineering sciences, material design, and system innovations are converging to address these challenges. The shift is going to be from legacy products like pacemaker and imaging systems to wearables for general fitness tracking and gait monitoring. Taking a step further, researchers are now developing and testing more focused miniaturized bioelectronic devices for recording and analyzing health data for detecting determinants of health and for medical interventions.

In diagnostics, non-invasive bioelectronic skin sensors that measure analytes in biofluids like saliva, tears, and sweat are showing promising results in assessing stress levels and detecting conditions like diabetes and cystic fibrosis. Researchers from the All India Institute of Medical Sciences (AIIMS) and Indian Institute of Technology (IIT) Delhi have developed a biosensor for detecting glucose in saliva samples for diabetes detection. The results can directly be viewed on the user’s smartphone. Many such studies are now underway in India.

Also Read: Healthy Lives: Everyone, Everywhere

Round-the-clock data collected from bioelectronic devices could replace the present time-point investigations and lead to better management of the health condition of patients. In addition, data from multiple people can help develop artificial intelligence algorithms and predictive tools. Such tools have already started showing analytic performance similar, and sometimes better than manual inspection by a specialist physician. In countries like India, that suffer from a shortage of qualified doctors in remote areas, such devices have immense potential. However, data standardization, data security, and privacy protection must be addressed and regulated before rolling out such interventions.

In the next few years, health monitoring, neural prosthetics, and biochemical prosthetics are expected to drive major developments in this space. Although the monitoring devices have already started testing the market in niche patient segments, it may take the implants another 5-10 years to reach health centers as they make their way through developmental and regulatory checkpoints.

The post Integrating Technologies to Better Healthcare appeared first on InnoHEALTH magazine.

The post VISIT LAUNCH SWASTHA BHARAT M-HEALTH APP appeared first on InnoHEALTH magazine.